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The present studies were aimed at further characterizing the 
interaction between basement membrane molecules and nor-
mal cultured human keratinocytes because of the intimate 
association between basal keratinocytes and the basement 
membrane. The studies show that keratinocytes adhere to 
type IV collagen-coated substrata to a greater degree than 
substrata coated with similar concentrations of fibronectin 
and laminin. To further define cell-binding regions within 
type IV collagen, studies were performed using purified pep-
sin-generated triple helical fragments of type IV collagen and 
show that keratinocytes bind to sites within the triple-helical 
region of type IV collagen. To delineate specific cell adhesion 
I n normal human skin, the epidermis is separated from the underlying dermal connective tissue by a basement mem-brane. This structure, which is an integral component of various tissues, has been ascribed to playa role in selective . filtration, in anchoring the epidermis to the dermis, in main-
taining the polarized differentiated state of the epidermis, and in 
providing guidance of cells during regenerative or reparative pro-
cesses. 
Pivotal to the further understanding of the molecular mecha-
nisms by which the basement membrane carries out its functions has 
been the unraveling of the morphology and biochemical composi-
tion of the basement membrane. Presently, it is recognized that the 
basement membrane is composed of various proteins, glycoproteins, 
and proteoglycans that undergo complex interactions resulting in 
an organized and functional meshwork structure. Specific compo-
nents that have been elucidated thus far include type IV collagen, 
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promoting sequences, we studied a series of chemically syn-
thesized peptides derived from the triple-helical region of 
type IV collagen. One peptide, designated Hep III, which is 
thirteen amino acids in length and binds heparin, was active 
in directly promoting keratinocyte adhesion. Furthermore, 
in competition assays, this peptide in solution was shown to 
inhibit keratinocyte adhesion to substrata coated with Hep III 
or intact type IV collagen. These studies show that keratino-
cytes bind directly to type IV collagen and chemically define 
a major cell -adhesion - promoting site within the triple-heli-
cal region.] Invest Dermatol 95:264-270, 1990 
type VII collagen, laminin, nidogen/ entactin, heparan sulfate prote-. 
oglycans, bullous pemphigoid antigen, and fibronectin (for recent 
reviews see [1,2]). 
The major component and ·structural scaffold of the basement 
membrane is type IV collagen [3], which is a high-molecular-
weight glycoprotein that exists as a flexibl e 420-nm rod as seen by 
rotary shadowing, and is composed of two a1 (IV) and one a2(IV) 
chains [4] . There are three primary regions within this molecule 
including a "7S" region, which is approximately the nrst 60 run 
from the amino terminus; a central 330-11111 region, which repre-
sents the major triple-helical portion interrupted in several areas 
with nonhelical segments; and a third region that is a collagenase 
resistant carboxy-terminal globular domain termed Ne1 [5]. 
Several functional properties of type IV collagen have been eluci-
dated. Type IV collagen has been shown to self assemble to form an 
irregular polygonal structure, which can function as a scaffold [6,7J. 
Moreover, type IV collagen is capable of binding to other basement-
membrane components including laminin [8,9], nidogen [10) , and 
heparan sulfate proteoglycans [9,11]. Notwithstanding its impor-
tance in providing mechanical stability to the basement membrane 
it is becoming increasingly apparent that type IV collagen also pia) 
a role in modulating cellular function . In this regard, numerous 
investigators have shown that both normal and transformed cell 
adhere to type IV collagen [12-18). Furthermore, there is evidence 
that receptors, such as integrins, exist on cell surfaces that bind type 
IV collagen directly (19-21]. 
In light of the intimate association between basal keratinocyt 
and the basement membrane, it is not surprising that several investi-
gators have shown that type IV collagen-coated surfaces promote 
keratinocyte adherence (12,22-24)' The present investigation w 
undertaken in order to further characterize the propensity of type 
IV collagen to directly promote adhesion of cultured normal human 
keratinocytes. Initially, the ability of normal human keratinocyres 
to bind to type IV collagen was compared to other extracellular 
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Figure 1. Kerarinocyte adherence to BSA, fibronectin, laminin, and type IV collagen. A: dose response. Microrirer we lls were coated with soluble BSA, 
fibronectin, laminin, or type IV collagen at concentrations from 0.05 -10 ,ug/well. Radiolabeled keratinocytes were added to each well and allowed to attach 
for 60 min, after wh ich the unattached cells were washed away, and the remaining radiolabcled cells were solubilized and quantified by liquid scintilation 
counting. B: kinetics. Substrata were coated with BSA, fibronectin, or laminin at 10 Ilg/well; or type IV collagen at 5 ,ug/ well. Radiolabeled keratinocytes were 
allowed to attach for 15 -120 min, after which the unattached cells were washed away and the attached cells were quantified as above. T he percent attachment 
was determined by the following equation : % attachment = DPM (cells) attached/DPM (cells) added X 100. BSA (solid circles) ; fibronectin (opell sql/ares); 
larninin (opel1 circles); and type IV collagen (solid sqllares). Determinations were done in triplicate. Bars, SO of the mean. 
matrix proteins. These studies indicated that when compared to 
laminin or fibronectin, a higher percentage ofkeratinocytes bind to 
type IV collagen coated surfaces. To further delineate specific bind-
ing domains within type IV collagen, we prepared purified proteo-
lyric fragments of type IV collagen and found that pepsin generated 
helical fragments promoted keratinocyte adhesion. Using this in-
formation, a number of pep tides were chemically synthesized from 
the h elical region of type IV collagen using the published sequence 
of the human al(IV) chain [25]. Of the pep tides synthesized, a 
peptide designated Hep III [26] was found to be active in promoting 
cell adhesion. Furthermore, the studies indicate that keratinocyte 
interaction with this peptide is specific and biologically relevant 
wi th respect to type IV collagen. 
MATERIALS AND METHODS 
Cell Culture Normal human keratinocyte cultures were initi-
ated from neonatal foreskins within 1 to 2 h after routine circumci-
sion of newborn male infants as previously described [27]. Tissue 
was obtained from a local nursery with the approval of the Human 
Studies Committee at the University of Minnesota. Primary and 
passage cu ltures were grown in complete keratinocyte growth me-
dium in a humidified atmosphere of 5% CO2 and 95% air at 3rc. 
Complete keratinocyte growth medium consists of nutrient kerat-
inocyte basal medium (Clonetics, San Diego, CA) supplemented 
with 5 X 10-7 M hydrocortisone, S J.lg/ml insulin, 10 ng/mJ epi-
dermal growth factor , and 140 J.lg/ml protein of bovine pituitary 
extract. Under the above-described conditions, keratinocyte cul-
tures are easily initiated and serially passaged forming monolayered 
undifferentiated cell colonies. However, because cultured neonatal 
keratinocytes undergo sensescence at 50 to 60 population doublings 
[28], only early passage cultures (under passage 3) were used in 
experiments. 
Protein Purification and Preparation of Proteolytic Frag-
ments of Type IV Collagen Type IV co llagen was extracted 
from the Engelbreth-Holm-Swarm (EHS) tumor grown in lathyri-
tic mice according to a modification of the method by Kleinmann et 
al [29] as previously described [30]. Laminin was also extracted from 
the EHS tumor and purified by neutral salt extraction using a modifi-
cation of the method ofTimpl et al [31]' as reported elsewhere [32]. 
Human plasma fibronectin was purified as a byproduct of factor VIII 
by sequential ion exchange and gelatin-affinity chromatography as 
described previously [33]. Triple-helical domain fragments of type 
IV collagen were produced by brief digestion of intact type IV 
collagen with pepsin, followed by gel filtration through a Sephacryl 
S-400 column as reported elsewhere [7,30] . The purity of the iso-
lated type IV collagen, laminin, fibronectin, and triple-helical do-
main fragments of type IV collagen was verified by SDS-polyacryl-
amide gel electrophoresis. The concentration of type IV collagen 
and the triple helical fragments of type IV collagen was determined 
spectrophotometrically according to the method of Waddel 
[18 ,34]. The concentration of laminin and fibronectin was deter-
mined spectrophotometrically by previously determined weight 
extinction coefficients [35,36]. 
Peptide Synthesis and Purification Peptides derived from the 
sequence of the triple-helical domain of the al (IV) chain of type IV 
collagen were synthesized by the Merrifield solid-phase method as 
described previously [26]. Briefly, deprotection and release of pep-
tides was achieved using hydrofluoric acid containing 10% anisole 
for 1 hat 4°C. Pep tides were then extracted with ether, dissolved in 
10% acetic acid, filtered, and lyophilized. Lyophilized crude poly-
peptides were purified by high-pressure liquid chromatography on a 
reverse-phase C-18 column using an elution gradient of 0 to 60% 
acetonitri le with 0.1 % trifluoroacetic acid in water. Purified poly-
peptides were characterized by amino acid analysis using a Beckman 
System 63090 amino acid ana lyzer. Finally, sequence determination 
was carried out by sequential Edman degradation from the amino 
terminus on a gas-phase sequenator, by the methodology of He wick 
et al [37]. 
Cell Adhesion Assay Assays for cell attachment to fibronectin, 
laminin, type IV collagen, proteolytic fragments of type IV colla-
gen, and chemically synthesized peptides were similar to those 
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Figure 2. Keratinocyte adherence to the triple-helical region of type IV collagen. A: dose response. Microtiter wells were coated with soluble BSA. type IV 
collagen. or triple-helical fragments at concentrations from 0.05 -10 ,ugjwell. Keratinocytes were allowed to attach for 60 min. after which unattached cells 
were washed away and the attached cells were quantified as described previously. B: kinetics. Substrata were coated with BSA or triple-helical fragments at 10 
J1g/ml; or type IV collagen at 5 J1g/well. Keratinocytes were allowed to attach for 15-120 min. after which the unattached cells were washed away and the 
attached cells were quantified as previously described. BSA (solid circles); type IV collagen (solid squares); and triple helical fragments (opell sqlIares), 
Determinations were done in triplicate. Bars, SD of the mean. 
previously described (33]. Briefly. various concentrations of the 
above proteins and peptides were added to 96-well Immulon 1 
plates (Dynatech Laboratories. Inc .• Aleranin, V A) and adsorbed 
overnight at 29°C. Three hours prior to the start of an assay, the 
plates were treated with phosphate-buffered saline containing 2 
mg/ml of fatty acid free bovine serum albumin (BSA) to block any 
non-specific binding sites of the plcstic surfaces. Rapidly proliferat-
ing cultures of normal human keratinocytes were incubated over-
night in medium containing 4 /.lCi/ml of (3H]thymidine (6,7 Ci/ 
mmole, New England Nuclear, Boston, MA). The flasks were 
washed 3 times with solution A [28] and harvested by gentle tryp-
sinization (5 min incubation at 37°C with 0.025% trypsin and 
0.01 % ethylenediaminetetraacetic acid [EDT A]). Trypsinization 
was terminated by washing the flasks with bovine pituitary extract 
free keratinocyte growth media to which soybean trypsin inhibitor, 
2 mg/ml BSA. and 0.02 M N-2-hydroxyethylpiperazine-N'-2-eth-
anesulfonic acid (HEPES) had been added. The cells were pelleted, 
resuspended in the same medium without soybean trypsin inhibitor, 
and passed through a nylon mesh to remove any cell aggregates. 
The blocking buffer was aspirated from the precoated wells and 100 
,ul of the cell suspension at 5 X 104 cells/ml was then added to each 
well and incubated at 3rc. After the designated time interval (15 
to 120 min), the non-adherent cells were aspirated off and the wells 
were rinsed 3 times with the media containing BSA. Adherent cells 
were solubilized with 0.5 N NaOH containing 1 % SDS, and quan-
tified in a scintillation counter. 
Competition of Cell Binding with Chemically Synthesized 
Peptides In these assays, the coating of plates with various ligands 
and harvesting of cells was similar to that described above. How_ 
ever, prior to transferring the cells to the coated plates the cells wen-
incubated with the test inhibitors at various concentrations (0 to 250 
,ug/mJ) for 30 min at 37 °C. After this incubation, the cells in the 
continued presence of peptide inhibitor were transferred to the 
plates previously coated with various proteins and cell binding was 
quantified as above. 
RESULTS 
Keratinocyte Adhesion to Type IV Collagen, Fibronectl.n, 
and. Laminin The first series of experiments were carried out til 
delineate the propensity of type IV collagen, fibronectin, and la-
minin to promote keratinocyte adhesion. Substrata were coat 
w ith various amounts (0.05 to 10 ,ug/well) of test proteins and 
keratinocytes were allowed to attach for 60 min (Fig. 1A). All three 
proteins were found to promote adhesion in a concentration-depen-
dent and saturable manner, although when compared to larninin 
and fibronectin, tYfe IV collagen-coated surfaces promoted a I 
higher degree of eel binding. By increasing the coating concentra. 
Table I. Keratinocyte Adhesion to Peptides Synthesized from the Helical Region of Type IV Collagen 
Peptide 
1009 
1018 
1019 
1043 
1086 
1134 (Hep Ill) 
1160 
Amino Acid 
Sequence' 
GEKGDKGLPGLD 
GPKGEPGKIVPLPG 
GVPGKDGQAGQPGQP 
GLPGKPGSMDKVDMGSMKGQK 
GHATEGPK 
GEFYFDLRLKGDK 
GPKGPRGKPGKDGDKGER 
Residue 
Numberb 
al 1115-1126 
al 633-645 
al 975-989 
al 930-957 
al 1228-1235 
al 531 -543 
al 300-317 
% Cell 
Adhesion' 
1 ± 1 
l±O 
3±1 
1 ± 0 
2± 1 
32± 3 
1 ± 0 
'Discontinuities of the Gly-X-Y sequence, when present, are underlined. 
bPeptides are numbered from the amino-termi~a\ end of type IV collagen. .. I 
'Microtiter wells were coated with soluble peptldes at 10 Jlg/ml. KeratInocytes were allowed to attach for 60 mIn. after whJch unattached ceIls were washed away and the attach 
cells were quantified as described previously. Data is expressed as mean ± SO. 
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Figure 3. Keratinocyte adherence to peptide Hep Ill . A : dose response. Microtiter we lls were coated with soluble BSA, type IV collagen, or peptide Hep III at 
concentrations from 0.05 -10 ,ug/well. Keratinocytcs were allowed to attach fo r 60 min, after which unattached ce lls were washed away and the attached cells 
were quantified as described previously. B: kinetics. Substrata were coated with BSA or peptide Hep III at 10 ,ug/ ml; or type IV collagen at 5,ug/ wel l. 
Keratinocytes were allowed to attach for 15 - 120 min, after which the unattached cells were washed away and the attached cel ls were quantified as previously 
described. BSA (solid circles); type IV collagen (so lid sqllares); and peptide Hep III (opell sq llares) . Determinations were done in triplica te. Bars, SO of the mean. 
[ion to 10 Ilg/we ll , maximal cell binding to type IV collagen was 
approximately 80% of the added keratinocytes, whereas cell bind-
ing approached but did not exceed 60% for fibronectin and 40% for 
laminin in a 60-min assay. In addition, when compared to fibronec-
[in and laminin, significant cell binding to type IV collagen oc-
curred at a much lower coating concentration. Specifically, at a 
coating concentration of 0.1 Ilg/well , type IV collagen promoted 
levels of cell adhesion that were 25 times greater than those pro-
duced by fibronectin and laminin at similar coating concentrations. 
To characterize the kinetics 'of cell binding to the test proteins, 
substrata were coated at concentrations resulting in maximal ce ll 
binding (5 Ilg/well for type IV coll agen, 10 ltg/well for fibronectin, 
and 10 Ilg/well for laminin) and keratinocyte adhesion was assessed 
after various time intervals (Fig. IB). Within 15 min all three pro-
teins promoted levels of cell adhesion from 20 to 60 times greater 
than control values (wells coated with BSA). Thereafter, cell adhe-
sion to all three proteins continued to increase up to 30 min, at 
which point cell binding to type IV collagen began plateauing and 
only modest increases in cell binding to fibronectin and laminin 
occurred. 
Keratinocyte Adhesion to Pepsin-Generated Helical Frag-
ments of Type IV Collagen Based on the abili ty of keratino-
cytes to bind to a high degree on type IV collagen -coated surfaces 
and the fac t that this molecul e represents a major component of the 
basement membrane, we focused subsequent experiments on fur-
ther characterizing specific cell-adhesion - promoting sites within 
type IV collagen. In this regard , fra gments containing the tripl e-he-
lical domain were prepared by pepsin di gestion of type IV coll agen, 
which degrades the globular N C I domain but preserves the collage-
nous region of the molecule. When substrata were coated with 
these helical-rich fragments, keratinocytes again bound in a con-
centration-dependent and saturable manner (Fig. 2A). When kerat-
inocytes were allowed to attach for 60 min , maximal binding ap-
proached 60% on substrata coated with helical fragments at 10 
Ilgjwell. The kinetics of keratinocyte adhesion was analyzed and 
within 15 min the substrata coated with the helical fragments pro-
moted keratinocyte adhesion 30 times greater than BSA-coated 
substrata (Fig 2B). As was seen with intact type IV collagen, cell 
binding to the helical fragments plateaued after 30 min. The maxi-
mal binding of cells to the helical fragments was approximately 
70% of that seen with the intact molecule over a similar time course 
and coating concentration. 
Keratinocyte Adhesion to Peptides Synthesized from the He-
lical Region of Type IV Collagen The above data indicated 
that keratinocytes can utilize regions within the triple-helica l do-
main of type IV coll agen fo r cell ad hesion. Based on this, peptides 
ranging fro m 8 to 21 amino acids were chemically synthesized from 
the known triple-hel ica l sequence of the O' I (IV) chain of type IV 
collagen [25,26]. T he ami no acid sequences, residue numbers, and 
cell-ad hes ion promoting activity of the peptides synth esized are 
displayed in Table I. Only one of the peptides, designated H ep III, 
displayed significa nt cell-adh esion- promoting activi ty. T his pep-
tide consists of 13 amino acid residues, binds heparin, and includes a 
discontinuity in the tripl e helix of type IV collagen [26]. Keratino-
cytes bound to peptide Hep III in a concentration-dependent fas h-
ion, with up to 40% of available cells binding at a coatin g concen-
tration of 10 ,Lig/ml after 60 min (Fig. 3A ). As was seen with intact 
type IV collagen and the pepsin-generated hel ical fragments of type 
IV coll agen, significant cell binding to Hep III occurred within 15 
min and onl y moderate increases in cell bind ing occurred over a 
longer time course (Fig 3B). N ot unexpected ly, although the cells 
were adherent to the peptide Hep III - coated substrata, even after 2 
h they failed to display the degree of spreading as seen with cell s 
attached to lam inin , fibronectin, type IV co llagen, and pepsin-gen-
erated helical frag ments over the same time course (Fig. 4). 
Specificity ofKeratinocyte Binding to Hep III and Relevance 
to Intact Type IV Collagen To assess w hether the in teraction 
between peptide Hep III and the kera tinocyte cell surface was spe-
cific, keratinocytes were preincubated with peptide H ep III in solu-
tion to test its ability to inhibi t cell binding to peptide Hep III -
coated substra ta. The results of these experiments ind icated that 
binding of cells to substrata coated with H ep III could be competed 
by Hep III 111 solutIOn, With up to 80% inhibition of cell adhesion 
observed (Fig SA). Other tripl e-helica l pep tides from type IV colla-
gen and a peptide that contains the RGD cell-binding domain did 
not inhibit keratinocyte adhesion on H ep III - coated substrata. The 
RGD containing peptide was active in inhibiting keratinocyte ad-
hesion to substrata coated with fibronectin (data not shown) . 
In order to determine whether peptide Hep III represents a func-
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Figure 4. Morphology ofkeratinocytes 2 h after plating on substrata coated with fibronectin (A), laminin (B), type JV collagen (C) I pepsin-generated heli<:a\ 
fragm ents of type IV collagen (D) , peptide H ep III (E), and BSA (F). After 2 h, the non-attached cells were washed away and the remaining cells were fixed, 
stained, and photographed under phase contrast microscopy. Magnification X 400. 
tionally active region of intact type IV collagen, similar competition 
studi es were carried out. When keratinocytes were preincubated 
with soluble peptide Hep 1II, up to 25% inhibition of cell adhesion 
to type IV collagen coated substrata was observed (Fig 5B). Again, 
other peptides representing areas within the triple-helical sequence 
and the RGD peptide did not inhibit cell binding to type IV 
collagen-coated substrata. To rule out cytotoxic effects of preincu-
bating keratinocytes with Hep III in solution, viabilities were deter-
mined by trypan blue exclusion and remained unaltered (e.g., 94 ± 
6% for control cells and 94 ± 2% for cells incubated with peptide 
Hep III at 500 )1gjml). 
DISCUSSION 
Unraveling the interaction between the basement membrane and 
the basal-layer keratinocytes of the epidermis is a major considera-
tion in understanding the molecular basis of such processes as 
wound healing, subepidermal blistering diseases, and tumor inva-
sion in malignant diseases of the skin. The increasing use of tumor 
models [38], which produce large amounts of basement membrane 
material, has shed a great deal of light on the structure and function 
of various basement membrane components (for recent reviews see 
[1 ,2)). Type IV collagen, which is localized almost exclusively to 
the basement membrane, has been reported by several investigators 
to directly promote keratinocyte adhesion [12,22 - 24,39,40]. How-
ever, the molecular basis for this interaction is poorly understood. 
The work presented in this manuscript, therefore, focused on fur-
ther delineating the interaction between keratinocytes and type IV 
coll agen. 
Initially our observations ofkeratinocyte interaction with type IV 
coll agen were compared to the interaction of these cells with other 
well-known extracellular matrix molecules. The results indicate 
tbat keratinocytes adhere to type IV collagen - coated substrata to a 
greater degree than substrata coated with similar concentrations o ~ 
fibron ectin or laminin. Furthermore, significant levels of cell adht'\ 
sion to type IV collagen were seen at coating concentrations tenfol 
less than that of laminin or fibronectin. Our results of cell adhesi 
were different than those of some previous investigations by Kuoo 
et al [39J and Clark et al [40J in which better adhesion of human, 
keratinocytes was demonstrated on fibronectin than on type f\ 
collagen. The reason for this apparent discrepancy between o~ 
results 'and theirs is not clear, although some differences in tissu~ 
culture systems and experimental conditions could be the cause. 
It is clear that the multidomain nature of type IV coJlagen ' 
relevant to various biologic activities. For example, with regard 
self assembly , it has been shown that dimeric structures are genet, 
ated by the interaction between NC1 domains , whereas tetrameri 
structures are formed by the latera l association of 7S segments (5, 
7J. Rotary shadowing electron microscopy has revealed thar th~ 
NC1 domain of type IV collagen binds heparan sulfate proteogl}\ 
can, whereas the triple-helical domain binds not only heraran sul, 
fate proteoglycan, but also fibronectin and laminin [9,11 . Extend, 
ing ceJl-mediated function to the multidomain model of type II' 
collagen, our studies indicate that keratinocytes are capable of bind, 
ing to the triple-helical region of the molecule in the absence of th 
NCl domain. This extends the findings of previous reports ' 
which various other cell types are capable of binding to triple-hell, 
cal fragments of typeIV collagen [16-18] . The data, however, d 
not exclude the possibility that keratinocytes may bind to the N q 
region of the molecule, and presently studies are underway to ad, 
dress this issue. 
Based on the ability of keratinocytes to bind to triple-heli \ 
fragments, we studied a series of chemically synthesized pepcid 
from the triple-helical domain based on the published sequence 
the human O!l(IV) chain [25}. A variety of peptides were prepaItl1 
that varied in size from 8 to 21 amino acids, displayed a range of n 
VOL. 95. NO.3 SEPTEMBER 1990 
120 
;,!! o 
~ 40 
~ 
« 
m 20 
c:: 
o 100 200 300 400 
COMPETING PEPTIDE 
CONCENTRATION (lJG/ML) 
500 
KERATINOCYTES ADHERE TO A COLLAGEN PEPTIDE 269 
I-
Z 
w 
110 
:E 100 
:I: 
U 
« 1= 90 
« 
;,!! o 
w 
> 
~ 
« 
-' w 
c:: 
80 
70 
oT 
o 
B 
100 200 300 400 
COMPETING PEPTIDE 
CONCENTRATION (lJG/ML) 
!?OO 
Figure 5. Effect of soluble Hep III on Hep III and type IV collagen - mediated attachment of keratinocytes. Microtiter wells were coated with Hep III at 5.0 
Jig/well (A) or type IV collagen at 1.0 Jig/well. Adherence of keratinocytes was then determined in the presence of soluble competing pep tides 1160 (open 
circles), 1018 (so lid circles). GRDGSP (opw squares), and Hep III (solid sq lIa res) at various concentrations (0- 500 Jig/ ml) . Data represent the mean percentage of 
cells adhering, relative to control adherence in the absence of competing peptide. Determinations were done in triplicate. Bars, SO of the mean. 
charge from -1 to +4, had a low hydropathy index, and included 
sequences with or without discontinuities in the standard collage-
nous gly-Xaa-Yaa sequence. Discontinuities were considered partic-
ularly important in the selection process in that these interruptions 
in the triple helix are highly conserved in different species indicat-
ing a possible functional role (41) . Of the peptides chosen, one 
peptide designated H ep III, which is thirteen amino acids in length 
and displays a discontinuity of seven amino acids, was found to 
significantly promote keratinocyte adhesion. Despite the fact that 
under our experimental conditions maximal cell binding and 
spreading was less than that seen with intact type IV collagen, it is 
srill remarkable that such a small sequence of type IV collagen is so 
potent at promoting cell adhesion. 
Because preincubation of keratinocytes with peptide H ep III in 
solution could inhibit their binding to Hep III-coated substrata, 
whereas preincubation with other triple helical peptides of type IV 
collagen or a peptide containing the RGD sequence had no inhibi-
tory activity, we conclude that the interaction between Hep III and 
the cell surface of the keratinocyte is specific in nature. Further-
more, because preincubation of keratinocytes with peptide Hep III 
in solution resulted in significant inhibition of cell binding to sub-
strata coated with intact type IV collagen, we also conclude that the 
Hep III sequence is biologically active in intact type IV collagen. 
The fac t that higher levels of inhibition are not seen on the intact 
molecule suggests that keratinocytes may adhere to type IV collagen 
through multiple distinct binding sequences possibly located in 
other segments of the triple-helical domain or the NC1 region. In 
this regard, it has been shown that certain cell types are carable of 
binding to the NC1 globular domain of type IV collagen 17,18) . 
Furthermore, if one considers other extracellular matrix compo-
nents, the phenomenon of multiple distinct cell adhesion promot-
ing domains within a given molecule has been well es tablished in 
fibronectin and laminin [33 ,42,43) . 
It has recently been reported that peptide Hep III specifically 
binds heparin and inhibits the binding of heparin to type IV colla-
gen [26). Heparin, which is a glycosaminoglycan, contains many of 
the same structural units as those found in heparan sulfate proteogly-
cans. Because it is known that cell-surface proteoglycans can act as 
receptors to various extracellular matrix components (for review see 
[44]), this may shed light on the mechanisms of keratinocyte bind-
ing to peptide Hep III. In this regard, it has been shown that kerat-
inocytes contain membrane-associated proteoglycans containing 
heparan sulfate, chondroitin sulfate, and dermatan sulfate (45). Fur-
thermore, business preincubation of keratinocytes with a peptide 
containing the RGD sequence did not inhibit keratinocyte binding 
to peptide Hep III or type IV collagen, this implies ~ell bi?-ding in 
this instance is not mediated by a RGD-dependent 1I1tegnn. Pres-
ently, studies are underway to address whether the interaction be-
tween keratinocytes and peptide Hep III is mediated through a 
cell-surface proteoglycan or integrin. 
In conclusion, our studies show that keratinocytes are capable of 
directly binding to type IV collagen. Furthermore, we have shown 
that at leas t one binding domain is located in the triple-helical 
region of the molecule. This binding site is at or near a discontinuity 
in the triple-helical sequence and, additionally, it represents a hepa-
rin-binding site. Hopefully, by further elucidating the mechanisms 
by which keratinocytes interact with extracellular matrix mole-
cules, light will be shed on cell adhesion and migration in normal 
and disease states. 
We are illdebted to Drs. Effie Tsilibary, Amy Skllbitz, alld Jim McCarthy Jar mallY 
helpJIII discussiolls alld sllggestiolls dllrillg the preparatioll oj this mallllscript alld to 
Dr. Biatlca COli ti-Trollcoll i Jar sYllthesis oj a Illllllber oj peptides. 
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